Category_ID,Number_of_Drugs,Category_Name
0,7,11-Hydroxycorticosteroids
1,7,17-Hydroxycorticosteroids
2,2,17-Ketosteroids
3,1,2-Amino-1-Phenylethanol Derivatives
4,3,3-Oxoandrosten (4) Derivatives
5,1,5-Androstanon (3) Derivatives
6,1,ACE Inhibitors and Calcium Channel Blockers
7,1,Abortifacient Agents
8,1,"Abortifacient Agents, Nonsteroidal"
9,1,Acetamides
10,1,Acetates
11,1,Acid Sensing Ion Channel Blockers
12,1,Acidifying Activity
13,1,Acids
14,4,"Acids, Acyclic"
15,4,"Acids, Carbocyclic"
16,1,"Acids, Noncarboxylic"
17,1,Adamantane Derivatives
18,1,Adamantanes
19,4,Adjuvants
20,6,"Adjuvants, Anesthesia"
21,1,"Adjuvants, Immunologic"
22,1,"Adjuvants, Pharmaceutic"
23,1,"Administration, Topical"
24,75,Adrenal Cortex Hormones
25,15,Adrenals
26,60,Adrenergic Agents
27,39,Adrenergic Agonists
28,25,Adrenergic Antagonists
29,7,Adrenergic Uptake Inhibitors
30,12,Adrenergic alpha-1 Receptor Agonists
31,4,Adrenergic alpha-1 Receptor Antagonists
32,6,Adrenergic alpha-2 Receptor Agonists
33,16,Adrenergic alpha-Agonists
34,5,Adrenergic alpha-Antagonists
35,14,Adrenergic and Dopaminergic Agents
36,8,Adrenergic beta-1 Receptor Agonists
37,8,Adrenergic beta-1 Receptor Antagonists
38,25,Adrenergic beta-2 Receptor Agonists
39,6,Adrenergic beta-3 Receptor Agonists
40,31,Adrenergic beta-Agonists
41,23,Adrenergic beta-Antagonists
42,1,Adrenergic beta2-Antagonists
43,13,Adrenergics for Systemic Use
44,18,"Adrenergics, Inhalants"
45,1,Adrenocortical Insufficiency
46,1,Adrenocorticotropic Hormone
47,13,Agents Causing Muscle Toxicity
48,34,Agents causing hyperkalemia
49,7,Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
50,56,Agents producing tachycardia
51,56,Agents that produce hypertension
52,3,Agents that produce neuromuscular block (indirect)
53,11,Agents that reduce seizure threshold
54,19,Agents to Treat Airway Disease
55,1,Alcohol Deterrents
56,55,Alcohols
57,51,Alimentary Tract and Metabolism
58,30,Alkaloids
59,1,Alkylating Activity
60,1,Alkylating Drugs
61,1,Alkylmercury Compounds
62,2,Alpha and Beta Blocking Agents
63,1,Alpha and Beta Blocking Agents and Thiazides
64,1,Alpha-Galactosidase A (alpha-Gal A) Pharmacological Chaperones
65,4,Alpha-and Beta-adrenergic Agonists
66,1,Amaryllidaceae Alkaloids
67,18,Amides
68,74,Amines
69,10,Amino Acids
70,4,"Amino Acids, Aromatic"
71,5,"Amino Acids, Cyclic"
72,1,"Amino Acids, Essential"
73,1,"Amino Acids, Neutral"
74,31,"Amino Acids, Peptides, and Proteins"
75,48,Amino Alcohols
76,2,Aminoalkyl Ethers
77,2,Aminobenzoates
78,1,Aminobutyrates
79,1,Ammonia Detoxicants
80,2,Ammonium Compounds
81,1,Amphetamine Anorectic
82,9,Amphetamines
83,1,Amylin Agonists
84,1,Amylin Analog
85,1,Amyloid
86,1,Amyloidogenic Proteins
87,6,Anabolic Agents
88,5,Anabolic Agents for Systemic Use
89,6,Anabolic Steroids
90,31,Analgesics
91,1,Analgesics and Anesthetics
92,4,"Analgesics, Non-Narcotic"
93,1,Androgen Receptor Antagonists
94,1,Androgen Receptor Inhibitors
95,8,Androgens
96,4,Androgens and Estrogens
97,1,Androstadienes
98,5,Androstan Derivatives
99,12,Androstanes
100,4,Androstanols
101,1,Androstenediols
102,7,Androstenes
103,4,Androstenols
104,10,Anesthetics
105,6,"Anesthetics, General"
106,4,"Anesthetics, Intravenous"
107,1,"Anesthetics, Local"
108,1,Aniline Compounds
109,1,Anions
110,1,Anorexigenic Agents & Respiratory and CNS Stimulants
111,1,"Anorexigenic Agents & Respiratory and Cerebral Stimulants, Miscellaneous"
112,1,Anterior Pituitary Lobe Hormones and Analogues
113,4,Anti-Acne Preparations
114,4,Anti-Acne Preparations for Topical Use
115,7,Anti-Allergic Agents
116,3,Anti-Anxiety Agents
117,21,Anti-Asthmatic Agents
118,2,Anti-Bacterial Agents
119,3,Anti-Dementia Drugs
120,6,Anti-Dyskinesia Agents
121,3,Anti-Estrogens
122,2,Anti-Gonadotropin-Releasing Hormones
123,4,Anti-Infective Agents
124,1,"Anti-Infective Agents, Local"
125,37,Anti-Inflammatory Agents
126,4,Anti-Obesity Agents
127,1,Anti-Parkinson Agents (Dopamine Agonist)
128,7,Anti-Parkinson Drugs
129,1,Anti-Ulcer Agents
130,1,Anti-epileptic Agent
131,1,Antiadrenal Preparations
132,1,"Antiadrenergic Agents, Centrally Acting"
133,1,"Antiadrenergic Agents, Ganglion-Blocking"
134,2,Antiandrogens
135,2,Antiandrogens and Estrogens
136,4,Antianemic Preparations
137,2,Antianginal Agents
138,26,Antiarrhythmic agents
139,2,Antibacterials for Systemic Use
140,1,Antibiotics for Topical Use
141,18,Anticholinergic Agents
142,3,Anticoagulants
143,10,Anticonvulsants
144,1,Anticorticosteroids
145,26,Antidepressive Agents
146,4,Antidepressive Agents Indicated for Depression
147,3,"Antidepressive Agents, Second-Generation"
148,1,Antidiarrheals
149,8,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"
150,2,Antidiuretic Agents
151,2,Antidiuretic Hormone Receptor Antagonists
152,3,Antidotes
153,3,Antiemetics
154,2,Antiemetics and Antinauseants
155,1,Antiglaucoma Agents
156,12,Antiglaucoma Preparations and Miotics
157,2,Antigonadotropins and Similar Agents
158,1,Antigout Preparations
159,2,Antihistamines for Systemic Use
160,38,Antihypertensive Agents
161,24,Antihypertensive Agents Indicated for Hypertension
162,4,Antiinfectives for Systemic Use
163,1,Antimetabolites
164,28,Antineoplastic Agents
165,1,"Antineoplastic Agents, Alkylating"
166,18,"Antineoplastic Agents, Hormonal"
167,1,"Antineoplastic Agents, Phytogenic"
168,22,Antineoplastic and Immunomodulating Agents
169,8,"Antiobesity Preparations, Excl. Diet Products"
170,1,Antioxidants
171,3,Antiplatelet agents
172,1,Antipropulsives
173,1,Antipruritics
174,1,Antipsoriatics
175,1,Antipsoriatics for Topical Use
176,2,Antipsychotic Agents
177,1,Antipsychotic Agents (Second Generation [Atypical])
178,2,Antirheumatic Agents
179,1,Antithrombins
180,7,Antitussive Agents
181,3,Antiviral Agents
182,2,Antivirals for Systemic Use
183,2,Antivirals for treatment of HCV infections
184,1,Aporphines
185,4,Appetite Depressants
186,1,Appetite Stimulants
187,4,Appetite Suppression
188,1,Arginine Vasopressin
189,4,Aromatase Inhibitors
190,1,Aryloxyacetic Acid Derivatives
191,4,Autacoids
192,54,Autonomic Agents
193,1,Aza Compounds
194,1,Azabicyclo Compounds
195,1,BCRP/ABCG2 Inducers
196,13,BCRP/ABCG2 Inhibitors
197,11,BCRP/ABCG2 Substrates
198,8,BSEP/ABCB11 Inhibitors
199,6,BSEP/ABCB11 Substrates
200,7,BSEP/ABCB11 inducers
201,1,Bacitracins
202,2,Barbiturates
203,1,Barbiturates and Derivatives
204,2,"Barbiturates, Plain"
205,1,Basic Ointments and Protectants
206,4,Benzazepines
207,28,Benzene Derivatives
208,1,Benzenesulfonamides
209,2,Benzhydryl Compounds
210,3,Benzoates
211,1,Benzodiazepines and benzodiazepine derivatives
212,1,Benzomorphan Derivatives
213,1,Benzomorphans
214,1,Benzophenones
215,1,Benzopyrans
216,7,Benzothiadiazines
217,1,Benzyl Compounds
218,6,Benzylidene Compounds
219,3,Benzylisoquinolines
220,12,Beta Blocking Agents and Thiazides
221,10,"Beta Blocking Agents, Non-Selective"
222,6,"Beta Blocking Agents, Non-Selective, and Thiazides"
223,8,"Beta Blocking Agents, Selective"
224,5,"Beta Blocking Agents, Selective, and Thiazides"
225,4,Beta blocking agents and calcium channel blockers
226,8,Beta-Blockers (Beta1 Selective)
227,2,Beta-adrenergic Agents
228,4,Bile Acid Preparations
229,5,Bile Acids and Salts
230,4,Bile Therapy
231,4,Bile acids and derivatives
232,5,Bile and Liver Therapy
233,6,Biogenic Amines
234,6,Biogenic Monoamines
235,6,Biological Factors
236,8,Blood Glucose Lowering Agents
237,1,Blood Substitutes and Perfusion Solutions
238,8,Blood and Blood Forming Organs
239,3,Bone Density Conservation Agents
240,1,Boron Compounds
241,1,Boronic Acids
242,37,Bradycardia-Causing Agents
243,4,Bridged-Ring Compounds
244,19,Bronchodilator Agents
245,1,Bunolol
246,1,Butyrates
247,1,Butyrophenone Derivatives
248,8,COMT Substrates
249,8,Calcium Channel Blockers
250,1,Calcium Channel Blockers (Nondihydropyridine)
251,1,"Calcium Channels, N-Type"
252,5,Calcium-Regulating Hormones and Agents
253,1,"Calmodulin, antagonists & inhibitors"
254,1,Cancer immunotherapy
255,1,Cannabinoid Receptor Agonists
256,2,Cannabinoids and similars
257,2,Carbazoles
258,10,Carbohydrates
259,5,Carbonic Anhydrase Inhibitors
260,1,Cardanolides
261,1,Cardenolides
262,1,Cardiac Glycosides
263,1,Cardiac Rhythm Alteration
264,14,Cardiac Stimulants Excl. Cardiac Glycosides
265,19,Cardiac Therapy
266,7,Cardiotonic Agents
267,4,Cardiotoxic antineoplastic agents
268,78,Cardiovascular Agents
269,1,Catecholamine-depleting Sympatholytic
270,8,Catecholamines
271,11,Catechols
272,2,Cell-mediated Immunity
273,82,Central Nervous System Agents
274,70,Central Nervous System Depressants
275,15,Central Nervous System Stimulants
276,8,Central Nervous System Stimulation
277,8,Centrally Acting Antiobesity Products
278,11,Centrally Acting Sympathomimetics
279,1,Chemically-Induced Disorders
280,2,Cholagogues and Choleretics
281,5,Cholanes
282,1,Cholelitholytic Agents
283,5,Cholic Acids
284,7,Cholinergic Agents
285,7,Cholinesterase Inhibitors
286,7,Cholinesterase substrates
287,1,Clomiphene
288,2,Coagulants
289,1,"Cocaine, antagonists & inhibitors"
290,13,Combination Contraceptives (with Estrogen and derivatives)
291,8,Combined Inhibitors of Serotonin/Norepinephrine Reuptake
292,1,Complex Mixtures
293,15,"Compounds used in a research, industrial, or household setting"
294,1,Conotoxins
295,17,"Contraceptive Agents, Female"
296,14,"Contraceptive Agents, Hormonal"
297,3,"Contraceptive Agents, Male"
298,16,"Contraceptives, Oral"
299,10,"Contraceptives, Oral, Hormonal"
300,8,"Contraceptives, Oral, Synthetic"
301,3,"Contraceptives, Postcoital"
302,3,Corpus Luteum Hormones
303,28,Corticosteroid Hormone Receptor Agonists
304,43,Corticosteroids
305,7,Corticosteroids Acting Locally
306,4,Corticosteroids for Local Oral Treatment
307,14,Corticosteroids for Systemic Use
308,13,"Corticosteroids for Systemic Use, Plain"
309,30,"Corticosteroids, Dermatological Preparations"
310,10,"Corticosteroids, Moderately Potent (Group II)"
311,16,"Corticosteroids, Potent (Group III)"
312,1,"Corticosteroids, Very Potent (Group IV)"
313,3,"Corticosteroids, Weak (Group I)"
314,1,Cortisol Synthesis Inhibitors
315,5,Cough and Cold Preparations
316,2,Cryoprotective Agents
317,1,Curare Alkaloids
318,1,Cyclic Lipopeptides
319,1,Cyclodextrins
320,2,Cyclohexanes
321,1,Cyclohexanols
322,5,Cycloparaffins
323,2,Cyclopropanes
324,1,"Cytochrome P-450 CYP11B2, antagonists & inhibitors"
325,6,Cytochrome P-450 CYP1A2 Inducers
326,6,Cytochrome P-450 CYP1A2 Inducers (strength unknown)
327,12,Cytochrome P-450 CYP1A2 Inhibitors
328,3,Cytochrome P-450 CYP1A2 Inhibitors (moderate)
329,6,Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)
330,2,Cytochrome P-450 CYP1A2 Inhibitors (strong)
331,3,Cytochrome P-450 CYP1A2 Inhibitors (weak)
332,16,Cytochrome P-450 CYP1A2 Substrates
333,2,Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
334,8,Cytochrome P-450 CYP2A6 Inducers
335,6,Cytochrome P-450 CYP2A6 Inhibitors
336,2,Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)
337,2,Cytochrome P-450 CYP2A6 Inhibitors (strong)
338,2,Cytochrome P-450 CYP2A6 Inhibitors (weak)
339,7,Cytochrome P-450 CYP2A6 Substrates
340,1,Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index
341,12,Cytochrome P-450 CYP2B6 Inducers
342,10,Cytochrome P-450 CYP2B6 Inducers (strength unknown)
343,1,Cytochrome P-450 CYP2B6 Inducers (strong)
344,1,Cytochrome P-450 CYP2B6 Inducers (weak)
345,8,Cytochrome P-450 CYP2B6 Inhibitors
346,1,Cytochrome P-450 CYP2B6 Inhibitors (moderate)
347,4,Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)
348,2,Cytochrome P-450 CYP2B6 Inhibitors (strong)
349,1,Cytochrome P-450 CYP2B6 Inhibitors (weak)
350,20,Cytochrome P-450 CYP2B6 Substrates
351,1,Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
352,5,Cytochrome P-450 CYP2C18 Substrates
353,1,Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index
354,10,Cytochrome P-450 CYP2C19 Inducers
355,10,Cytochrome P-450 CYP2C19 Inducers (strength unknown)
356,17,Cytochrome P-450 CYP2C19 Inhibitors
357,1,Cytochrome P-450 CYP2C19 Inhibitors (moderate)
358,6,Cytochrome P-450 CYP2C19 Inhibitors (weak)
359,28,Cytochrome P-450 CYP2C19 Substrates
360,3,Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
361,9,Cytochrome P-450 CYP2C19 inhibitors (strength unknown)
362,12,Cytochrome P-450 CYP2C8 Inducers
363,12,Cytochrome P-450 CYP2C8 Inducers (strength unknown)
364,1,Cytochrome P-450 CYP2C8 Inducers (strong)
365,18,Cytochrome P-450 CYP2C8 Inhibitors
366,4,Cytochrome P-450 CYP2C8 Inhibitors (moderate)
367,11,Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)
368,4,Cytochrome P-450 CYP2C8 Inhibitors (strong)
369,1,Cytochrome P-450 CYP2C8 Inhibitors (weak)
370,22,Cytochrome P-450 CYP2C8 Substrates
371,9,Cytochrome P-450 CYP2C9 Inducers
372,9,Cytochrome P-450 CYP2C9 Inducers (strength unknown)
373,19,Cytochrome P-450 CYP2C9 Inhibitors
374,1,Cytochrome P-450 CYP2C9 Inhibitors (moderate)
375,16,Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)
376,1,Cytochrome P-450 CYP2C9 Inhibitors (strong)
377,2,Cytochrome P-450 CYP2C9 Inhibitors (weak)
378,30,Cytochrome P-450 CYP2C9 Substrates
379,3,Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
380,27,Cytochrome P-450 CYP2D6 Inhibitors
381,3,Cytochrome P-450 CYP2D6 Inhibitors (moderate)
382,15,Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)
383,1,Cytochrome P-450 CYP2D6 Inhibitors (strong)
384,9,Cytochrome P-450 CYP2D6 Inhibitors (weak)
385,52,Cytochrome P-450 CYP2D6 Substrates
386,3,Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
387,4,Cytochrome P-450 CYP2E1 Inducers
388,4,Cytochrome P-450 CYP2E1 Inducers (strength unknown)
389,1,Cytochrome P-450 CYP2E1 Inducers (weak)
390,6,Cytochrome P-450 CYP2E1 Inhibitors
391,3,Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)
392,1,Cytochrome P-450 CYP2E1 Inhibitors (strong)
393,3,Cytochrome P-450 CYP2E1 Inhibitors (weak)
394,8,Cytochrome P-450 CYP2E1 Substrates
395,2,Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index
396,43,Cytochrome P-450 CYP3A Inducers
397,4,Cytochrome P-450 CYP3A Inducers (strong)
398,35,Cytochrome P-450 CYP3A Inhibitors
399,136,Cytochrome P-450 CYP3A Substrates
400,42,Cytochrome P-450 CYP3A4 Inducers
401,2,Cytochrome P-450 CYP3A4 Inducers (moderate)
402,36,Cytochrome P-450 CYP3A4 Inducers (strength unknown)
403,4,Cytochrome P-450 CYP3A4 Inducers (strong)
404,2,Cytochrome P-450 CYP3A4 Inducers (weak)
405,33,Cytochrome P-450 CYP3A4 Inhibitors
406,5,Cytochrome P-450 CYP3A4 Inhibitors (moderate)
407,19,Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)
408,4,Cytochrome P-450 CYP3A4 Inhibitors (strong)
409,7,Cytochrome P-450 CYP3A4 Inhibitors (weak)
410,135,Cytochrome P-450 CYP3A4 Substrates
411,9,Cytochrome P-450 CYP3A4 Substrates (strength unknown)
412,6,Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
413,23,Cytochrome P-450 CYP3A5 Inducers
414,3,Cytochrome P-450 CYP3A5 Inducers (moderate)
415,18,Cytochrome P-450 CYP3A5 Inducers (strength unknown)
416,1,Cytochrome P-450 CYP3A5 Inducers (strong)
417,2,Cytochrome P-450 CYP3A5 Inducers (weak)
418,9,Cytochrome P-450 CYP3A5 Inhibitors
419,1,Cytochrome P-450 CYP3A5 Inhibitors (moderate)
420,6,Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)
421,2,Cytochrome P-450 CYP3A5 Inhibitors (weak)
422,33,Cytochrome P-450 CYP3A5 Substrates
423,1,Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
424,4,Cytochrome P-450 CYP3A7 Inducers
425,4,Cytochrome P-450 CYP3A7 Inducers (strength unknown)
426,6,Cytochrome P-450 CYP3A7 Inhibitors
427,5,Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)
428,1,Cytochrome P-450 CYP3A7 Inhibitors (weak)
429,22,Cytochrome P-450 CYP3A7 Substrates
430,1,Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
431,49,Cytochrome P-450 Enzyme Inducers
432,70,Cytochrome P-450 Enzyme Inhibitors
433,170,Cytochrome P-450 Substrates
434,1,Cytochrome P450 11B1 Inhibitors
435,1,Cytolytic Agent
436,1,Cytosine Nucleotides
437,2,Decongestants and Antiallergics
438,1,Decreased Autonomic Ganglionic Activity
439,1,Decreased Cell Membrane Integrity
440,1,Decreased Cell Wall Synthesis & Repair
441,2,Decreased Central Nervous System Disorganized Electrical Activity
442,1,Decreased GnRH Secretion
443,2,Decreased Renal K+ Excretion
444,1,Decreased Sympathetic Activity
445,3,Delayed-Action Preparations
446,1,Dental Agents
447,36,Dermatologicals
448,1,Dextrins
449,6,Diagnostic Agents
450,1,Diagnostic Uses of Chemicals
451,1,"Diazepines, Oxazepines, Thiazepines and Oxepines"
452,1,"Diet, Food, and Nutrition"
453,1,Dietary Carbohydrates
454,2,Dietary Supplements
455,1,Digitalis Glycosides
456,1,Dimethylamines
457,1,Diphenylpropylamine Derivatives
458,2,Direct Acting Antivirals
459,1,Disaccharides
460,36,Diuretics
461,15,Dopamine Agents
462,1,Dopamine Agonists
463,1,Dopamine And Norepinephrine Reuptake Inhibitors
464,1,Dopamine Antagonists
465,1,Dopamine D2 Receptor Antagonists
466,11,Dopamine Uptake Inhibitors
467,1,"Dopamine, metabolism"
468,1,Drug Delivery Systems
469,5,Drugs Used in Addictive Disorders
470,2,Drugs Used in Alcohol Dependence
471,8,Drugs Used in Diabetes
472,1,Drugs Used in Erectile Dysfunction
473,3,Drugs Used in Opioid Dependence
474,19,Drugs causing inadvertant photosensitivity
475,1,Drugs for Acid Related Disorders
476,9,Drugs for Constipation
477,2,Drugs for Functional Gastrointestinal Disorders
478,30,Drugs for Obstructive Airway Diseases
479,1,Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
480,71,Drugs that are Mainly Renally Excreted
481,1,"EENT Drugs, Miscellaneous"
482,3,Eicosanoids
483,1,Electrolyte Solutions
484,1,Electrolytes
485,1,Emetics
486,16,Endocrine Therapy
487,1,Enemas
488,1,Enzyme Activators
489,1,Enzyme Inducing Antiepileptic Drugs
490,25,Enzyme Inhibitors
491,4,Epinephrine and similars
492,2,Epithelial Sodium Channel Blockers
493,1,Erythropoiesis-Stimulating Agents
494,1,Esters of Benzoic Acid
495,7,Estradiol Congeners
496,1,"Estradiol, agonists"
497,8,Estranes
498,2,Estren Derivatives
499,8,Estrenes
500,3,Estrogen Agonist-antagonists
501,6,Estrogen Agonist/Antagonist
502,9,Estrogen Antagonists
503,3,Estrogen Contraceptives
504,1,Estrogen Receptor Antagonists
505,6,Estrogen Receptor Modulators
506,1,"Estrogenic Steroids, Alkylated"
507,7,Estrogens
508,1,"Estrogens, Antiestrogens, and Estrogen Agonist-Antagonists"
509,1,"Estrogens, Non-Steroidal"
510,2,"Estrogens, agonists"
511,19,Ethanolamines
512,17,Ethylamines
513,1,Ethylene Glycols
514,4,Excitatory Amino Acid Agents
515,5,Excitatory Amino Acid Antagonists
516,3,Experimental Unapproved Treatments for COVID-19
517,1,Factor VIII Activator
518,1,Farnesoid X Receptor Agonist
519,1,Farnesoid X Receptor Agonists
520,4,Fatty Acids
521,3,"Fatty Acids, Unsaturated"
522,1,"Fatty Acids, Volatile"
523,1,Fatty Alcohols
524,4,Fentanyl and fentanyl analogues
525,4,Fertility Agents
526,4,"Fertility Agents, Female"
527,1,Fluids and Secretions
528,2,Folic Acid Analogues
529,1,Folic Acid Antagonists
530,1,Folic Acid and Derivatives
531,1,Food
532,91,Fused-Ring Compounds
533,6,GABA Agents
534,1,GABA Agonists
535,5,GABA Modulators
536,1,GABA-B Receptor Agonists
537,1,GLP-1 Agonists
538,1,Gaba-derivative Skeletal Muscle Relaxants
539,2,Ganglion Blockers
540,1,Gastrins
541,12,Gastrointestinal Agents
542,2,Gastrointestinal Hormones
543,62,Genito Urinary System and Sex Hormones
544,1,Glucagon-like peptide-1 (GLP-1) analogues
545,1,Glucans
546,18,Glucocorticoids
547,1,Glycolates
548,1,Glycols
549,2,Glycoside Hydrolase Inhibitors
550,3,Glycosides
551,13,Gonadal Hormones
552,13,Gonadal Steroid Hormones
553,5,Gonadotropin Releasing Hormone Receptor Agonist
554,5,Gonadotropin Releasing Hormone Receptor Agonists
555,1,Gonadotropin Releasing Hormone Receptor Antagonists
556,1,"Gonadotropin-Releasing Hormone, agonists"
557,2,"Gonadotropin-Releasing Hormone, antagonists & inhibitors"
558,1,Gonadotropin-releasing Hormone Antagonists
559,7,Gonadotropin-releasing hormone agonist
560,1,Gonadotropins
561,3,Gonadotropins and Antigonadotropins
562,1,Growth Hormone Secretagogue Receptor Agonist
563,1,Growth Hormone Secretagogue Receptor Agonists
564,1,Growth Substances
565,1,Guanylate Cyclase Activators
566,1,Guanylate Cyclase-C Agonist
567,1,Guanylyl Cyclase C Agonists
568,19,Gynecological Antiinfectives and Antiseptics
569,2,HCV NS3/4A Protease Inhibitors
570,1,HCV Protease Inhibitors
571,1,Hallucinogens
572,1,Harringtonines
573,1,Hematinics
574,7,Hematologic Agents
575,3,Hemostatics
576,2,Hepatotoxic Agents
577,1,Herbs and Natural Products
578,1,"Heroin, agonists"
579,64,"Heterocyclic Compounds, Fused-Ring"
580,1,Hexanols
581,5,High-Ceiling Diuretics
582,2,High-Ceiling Diuretics and Potassium-Sparing Agents
583,9,High-risk opioids
584,4,Highest Risk QTc-Prolonging Agents
585,1,Histamine Agents
586,3,Histamine Antagonists
587,3,Histamine H1 Antagonists
588,1,Histamine H2 Antagonists
589,1,Histamine H3 Antagonists
590,19,Hormonal Contraceptives for Systemic Use
591,18,Hormone Antagonists
592,8,Hormone Antagonists and Related Agents
593,74,Hormones
594,8,Hormones and Related Agents
595,89,"Hormones, Hormone Substitutes, and Hormone Antagonists"
596,1,Hydrazines
597,1,"Hydrocarbons, Chlorinated"
598,2,"Hydrocarbons, Halogenated"
599,4,Hydrocortisone and derivatives
600,3,Hydroxy Acids
601,1,Hydroxybenzoates
602,8,Hydroxycorticosteroids
603,1,Hydroxylamines
604,1,Hydroxyprogesterones
605,1,Hydroxyquinolines
606,58,Hyperglycemia-Associated Agents
607,6,Hypnotics and Sedatives
608,5,Hypoglycemia-Associated Agents
609,56,Hypotensive Agents
610,10,Hypothalamic Hormones
611,3,"Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors"
612,1,Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
613,1,I.V. Solution Additives
614,2,Imides
615,1,Imines
616,1,Imino Acids
617,2,Imino Pyranoses
618,2,Imino Sugars
619,3,Immunologic Factors
620,47,Immunosuppressive Agents
621,1,Immunotherapy
622,1,Increased Blood Pressure
623,1,Increased Coagulation Factor VIII Activity
624,1,Increased Coagulation Factor VIII Concentration
625,11,Increased Diuresis
626,4,Increased Diuresis at Loop of Henle
627,2,Increased Histamine Release
628,1,Increased IgG Production
629,1,Increased Medullary Respiratory Drive
630,1,Increased Norepinephrine Activity
631,4,Increased Sympathetic Activity
632,1,Incretin Mimetics
633,1,Indans
634,2,Indenes
635,2,Indole Alkaloids
636,4,Indoles
637,2,Indolizidines
638,2,Indolizines
639,1,Inducers of Drug Clearance
640,3,Inflammation Mediators
641,1,Influenza A M2 Protein Inhibitor
642,1,Inhibit Ovum Fertilization
643,7,Intestinal Antiinflammatory Agents
644,1,"Intraocular Pressure, drug effects"
645,2,Intravaginal Contraceptives
646,1,Ions
647,1,Irrigating Solutions
648,2,Isoindoles
649,3,Isonipecotic Acids
650,4,Isoquinolines
651,3,Ketones
652,2,Ketosteroids
653,2,Kinase Inhibitor
654,1,Laboratory Chemicals
655,1,Lactams
656,2,Lactones
657,5,Laxatives
658,1,"Laxatives, magnesium containing"
659,1,Lipid Modifying Agents
660,6,Lipids
661,1,Lipopeptide Antibacterial
662,1,Lipopeptides
663,1,Liver Therapy
664,1,"Liver Therapy, Lipotropics"
665,1,Local Anesthetics (Ester)
666,1,Local Hemostatics
667,7,Long-acting beta-adrenoceptor agonists
668,5,Low-Ceiling Diuretics and Potassium-Sparing Agents
669,5,"Low-Ceiling Diuretics, Excl. Thiazides"
670,1,Luteolytic Agents
671,1,M2 Protein Inhibitors
672,4,MATE 1 Inhibitors
673,2,MATE 1 Substrates
674,2,MATE 2 Inhibitors
675,1,MATE 2 Substrates
676,4,MATE inhibitors
677,2,MATE substrates
678,1,Macromolecular Substances
679,1,Magnesium Compounds
680,1,Magnesium Salts
681,1,Marine Toxins
682,1,Megestrol
683,1,Melanocortins
684,37,Membrane Transport Modulators
685,1,Mercurial Diuretics
686,1,Mesenchymal Epithelial Transition Inhibitors
687,1,Metal cations
688,1,Metal divalent cations
689,1,Metaproterenol
690,4,Methemoglobinemia Associated Agents
691,2,Methylphenidate and isomer
692,1,Micronutrients
693,2,Mineral Supplements
694,2,Mineralocorticoid (Aldosterone) Receptor Antagonists
695,4,Mineralocorticoid Receptor Antagonists
696,2,Mineralocorticoids
697,2,Miscellaneous Anticonvulsants
698,2,Miscellaneous Antidepressants
699,2,Miscellaneous Antiemetics
700,1,Miscellaneous Calcium-channel Blocking Agents
701,1,Miscellaneous Central Nervous System Agents
702,4,Miscellaneous GI Drugs
703,2,Miscellaneous Therapeutic Agents
704,1,Miscellaneous Vasodilatating Agents
705,4,Mixed Agonist / Antagonist Opioids
706,6,Moderate Risk QTc-Prolonging Agents
707,1,Molecular Probes
708,1,Mollusk Venoms
709,1,Monoamine Oxidase A Inhibitors
710,8,Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates
711,3,Monoamine Oxidase A Substrates
712,2,Monoamine Oxidase B Inhibitors
713,4,Monoamine Oxidase Inhibitors
714,2,"Monoamine Oxidase Inhibitors, Non-Selective"
715,2,Morphinan Derivatives
716,19,Morphinans
717,8,Morphine Derivatives
718,2,Morpholines
719,8,Muscarinic Antagonists
720,6,Muscle Relaxants
721,2,"Muscle Relaxants, Centrally Acting Agents"
722,5,"Muscle Relaxants, Peripherally Acting Agents"
723,6,Musculo-Skeletal System
724,1,Mustard Compounds
725,3,Mydriatics
726,2,Mydriatics and Cycloplegics
727,2,Myelosuppressive Agents
728,1,N-Calcium Channel Receptor Antagonists
729,1,N-methyl-D-aspartate Receptor Antagonist
730,7,NMDA Receptor Antagonists
731,2,NS3/4A Protease Inhibitors
732,4,Naphthalenes
733,22,Narcotics
734,11,Narrow Therapeutic Index Drugs
735,4,Nasal Decongestants
736,3,Nasal Decongestants for Systemic Use
737,19,Nasal Preparations
738,28,Natriuretic Agents
739,7,Natural Opium Alkaloids
740,5,"Natural and Semisynthetic Estrogens, Plain"
741,9,Negative Inotrope
742,7,Nephrotoxic agents
743,11,Nerve Tissue Proteins
744,65,Nervous System
745,3,Neuraxial Anesthetics
746,1,Neuroactive Steroid Gamma-Aminobutyric Acid (GABA) A Receptor Positive Modulators
747,2,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator
748,4,Neuromuscular Agents
749,4,Neuromuscular Blocking Agents
750,1,Neuromuscular Nondepolarizing Blockade
751,4,Neuromuscular-Blocking Agents (Nondepolarizing)
752,11,Neuropeptides
753,3,Neuroprotective Agents
754,2,Neurotoxic agents
755,84,Neurotransmitter Agents
756,14,Neurotransmitter Uptake Inhibitors
757,1,Nicotinic Acids
758,11,Nicotinic Antagonists
759,2,Nitrate Vasodilator
760,2,Nitrates and Nitrites
761,2,Nitric Oxide Donors
762,2,Nitriles
763,2,Nitrogen Compounds
764,1,Nitrogen Mustard Compounds
765,8,Non Potassium Sparing Diuretics
766,1,Non-Selective Calcium Channel Blockers
767,1,Non-Standardized Chemical Allergen
768,3,Non-selective Beta-adrenergic Agonists
769,1,Nonergot-derivative Dopamine Receptor Agonists
770,1,Nonsteroidal Mineralocorticoid-Receptor Antagonist
771,2,Nootropic Agents
772,1,Norbornanes
773,2,Norepinephrine Releasing Agents
774,2,Norepinephrine Reuptake Inhibitor
775,4,Norepinephrine Uptake Inhibitors
776,1,"Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic"
777,1,"Norepinephrine, antagonists & inhibitors"
778,11,Norpregnanes
779,2,Norpregnatrienes
780,8,Norpregnenes
781,12,Norsteroids
782,2,Noxae
783,1,Nucleic Acid Synthesis Inhibitors
784,1,"Nucleic Acids, Nucleotides, and Nucleosides"
785,1,Nucleotides
786,3,OAT1/SLC22A6 Substrates
787,14,OAT1/SLC22A6 inhibitors
788,2,OAT3/SLC22A8 Inducers
789,8,OAT3/SLC22A8 Inhibitors
790,16,OAT3/SLC22A8 Substrates
791,1,OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index
792,1,OATP1B1/SLCO1B1 Inducers
793,14,OATP1B1/SLCO1B1 Inhibitors
794,9,OATP1B1/SLCO1B1 Substrates
795,1,OATP1B3 inducers
796,6,OATP1B3 inhibitors
797,9,OATP1B3 substrates
798,3,OATP2B1/SLCO2B1 substrates
799,9,OCT1 inhibitors
800,9,OCT1 substrates
801,15,OCT2 Inhibitors
802,8,OCT2 Substrates
803,1,Ointments
804,10,Oligopeptides
805,3,Onium Compounds
806,3,Ophthalmics
807,5,Ophthalmological and Otological Preparations
808,30,Ophthalmologicals
809,16,Opiate Agonists
810,21,Opiate Alkaloids
811,2,Opiate Antagonists
812,4,Opiate Partial Agonists
813,14,Opioid Agonist
814,2,Opioid Agonist/Antagonist
815,5,Opioid Anesthetics
816,12,Opioid Antagonists
817,27,Opioids
818,4,"Opioids, Anilidopiperidine"
819,5,Opium Alkaloids and Derivatives
820,1,Optical Imaging Agent
821,4,Oral Hypoglycemics
822,2,Organic Anion Transporting Polypeptide 1B1 Inhibitors
823,2,Organic Anion Transporting Polypeptide 1B3 Inhibitors
824,1,Organic Anion Transporting Polypeptide 2B1 Inhibitors
825,2,Organic Nitrates
826,1,Organomercury Compounds
827,1,Organometallic Compounds
828,1,Oripavine Derivatives
829,1,Osmotic Activity
830,4,Osmotic Laxatives
831,1,Other Cold and Cough Preparations
832,1,Other Diagnostics
833,2,Other Miscellaneous Therapeutic Agents
834,6,Otologicals
835,3,Ototoxic agents
836,1,"Ovulation Stimulants, Synthetic"
837,4,Oxazines
838,1,Oxytocin and Analogues
839,14,P-glycoprotein inducers
840,27,P-glycoprotein inhibitors
841,49,P-glycoprotein substrates
842,5,P-glycoprotein substrates with a Narrow Therapeutic Index
843,3,Pancreatic Hormones
844,2,Parasympathomemetic (Cholinergic) Agents
845,1,Parasympathomimetics
846,1,Partial Opioid Agonist/Antagonist
847,2,Pentacyclic Triterpenes
848,1,"Pentagastrin, antagonists & inhibitors"
849,14,Peptide Hormones
850,20,Peptides
851,2,"Peptides, Cyclic"
852,91,Peripheral Nervous System Agents
853,4,Peripheral Opioid Receptor Antagonists
854,3,Peripheral Vasodilators
855,1,Peripheral alpha-1 blockers
856,1,Pharmaceutic Aids
857,4,Pharmaceutical Preparations
858,20,Phenanthrenes
859,19,Phenethylamines
860,1,Phenobarbital and similars
861,13,Phenols
862,1,Phenoxyacetates
863,14,Phenoxypropanolamines
864,3,Phenylacetates
865,1,Phenylalkylamine Derivatives
866,6,Phenylpiperidine opioids
867,1,Phenylurea Compounds
868,19,Photosensitizing Agents
869,1,Phthalimides
870,1,"Pigments, Biological"
871,1,Piperazines
872,1,Piperidinedione Derivatives
873,18,Piperidines
874,2,Piperidones
875,2,Pituitary
876,1,Pituitary Function
877,1,Pituitary Hormone Release Inhibiting Hormones
878,6,Pituitary Hormone-Releasing Hormones
879,5,Pituitary Hormones
880,1,"Pituitary Hormones, Anterior"
881,4,"Pituitary Hormones, Posterior"
882,9,Pituitary and Hypothalamic Hormones and Analogues
883,3,Platelet Aggregation Inhibitors Excl. Heparin
884,1,Polymers
885,1,Polysaccharides
886,3,Posterior Pituitary Lobe Hormones
887,4,Potassium-Sparing Diuretics
888,25,Potential QTc-Prolonging Agents
889,2,Prednisolone and Prodrugs
890,5,Pregnadien Derivatives
891,6,Pregnadienediols
892,31,Pregnadienes
893,15,Pregnadienetriols
894,50,Pregnanes
895,1,Pregnen (4) Derivatives
896,13,Pregnenediones
897,18,Pregnenes
898,1,Preparations Increasing Uric Acid Excretion
899,1,Pro-Opiomelanocortin
900,1,Prodrugs
901,5,Progesterone Congeners
902,2,Progesterone and Derivatives
903,1,"Progesterone, antagonists & inhibitors"
904,13,Progestin Contraceptives
905,2,Progestin-containing Intrauterine Device
906,19,Progestins
907,12,"Progestogens and Estrogens, Sequential Preparations"
908,24,Propanolamines
909,24,Propanols
910,1,Propionates
911,1,Propylamines
912,3,Prostacyclin Analogues
913,1,Prostacycline Vasodilator
914,3,Prostaglandins
915,2,Prostaglandins I
916,1,"Prostaglandins, Synthetic"
917,2,Protease Inhibitors
918,1,Proteasome Inhibitors
919,12,Protective Agents
920,1,"Protein Kinase C, antagonists & inhibitors"
921,2,Protein Kinase Inhibitors
922,1,Protein Synthesis Inhibitors
923,1,"Protein-Lysine 6-Oxidase, antagonists & inhibitors"
924,1,Proteinogenic Amino Acids
925,13,Proteins
926,1,"Proto-Oncogene Proteins c-met, antagonists & inhibitors"
927,22,Psychoanaleptics
928,7,Psycholeptics
929,11,"Psychostimulants, Agents Used for ADHD and Nootropics"
930,14,Psychotropic Drugs
931,4,Pteridines
932,3,Pterins
933,1,Purine Derivatives
934,1,Purines
935,1,Purinones
936,1,Pyrans
937,2,Pyrazines
938,3,Pyridines
939,1,Pyrimidine Nucleotides
940,5,Pyrimidines
941,4,Pyrimidinones
942,4,Pyrrolidines
943,3,Pyrrolidinones
944,39,QTc Prolonging Agents
945,1,QTc shortening agents
946,1,Quaternary Ammonium Compounds
947,1,Quinazolines
948,1,Quinazolinones
949,3,Quinolines
950,1,Quinolones
951,1,Receptor Tyrosine Kinase Inhibitors
952,1,"Receptors, AMPA"
953,1,Replacement Preparations
954,29,Reproductive Control Agents
955,33,Respiratory System Agents
956,1,Respiratory and CNS Stimulants
957,1,Ribonucleotides
958,1,Salicylamides
959,1,Secologanin Tryptamine Alkaloids
960,1,Secondary and Tertiary Amines
961,2,Selective Beta 1-adrenergic Agonists
962,15,Selective Beta 2-adrenergic Agonists
963,1,Selective Calcium Channel Blockers With Direct Cardiac Effects
964,8,Selective Estrogen Receptor Modulators
965,2,Selective Serotonin Reuptake Inhibitors
966,4,Semi-synthetic Opioids
967,27,Sensory Organs
968,36,Sensory System Agents
969,1,Serine Protease Inhibitors
970,48,Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
971,3,Serotonin 5-HT1 Receptor Antagonists
972,3,Serotonin 5-HT1A Receptor Antagonists
973,1,Serotonin 5-HT2 Receptor Agonists
974,1,Serotonin 5-HT2 Receptor Antagonists
975,1,Serotonin 5-HT2C Receptor Antagonists
976,20,Serotonin Agents
977,14,Serotonin Modulators
978,1,Serotonin Receptor Agonists
979,5,Serotonin Receptor Antagonists
980,3,Serotonin and Noradrenaline Reuptake Inhibitors
981,37,Sex Hormones and Modulators of the Genital System
982,1,Sigma-1 Agonist
983,1,Sigma-1 Receptor Agonists
984,1,Sodium
985,2,Sodium Channel Blockers
986,12,Sodium Chloride Symporter Inhibitors
987,5,Sodium Potassium Chloride Symporter Inhibitors
988,1,"Sodium-Glucose Transport Proteins, antagonists & inhibitors"
989,1,"Sodium-Glucose Transporter 1, antagonists & inhibitors"
990,4,Sodium-Glucose Transporter 2 Inhibitors
991,4,Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
992,1,Solvents
993,1,Somatostatin Agonists
994,1,Somatostatin Receptor Agonists
995,1,Somatostatin and Analogues
996,1,Standardized Chemical Allergen
997,1,Starch
998,4,Steroid Synthesis Inhibitors
999,90,Steroids
1000,2,"Steroids, Chlorinated"
1001,19,"Steroids, Fluorinated"
1002,6,Stilbenes
1003,5,Stimulants
1004,1,Stimulation Large Intestine Fluid/Electrolyte Secretion
1005,4,Stomatological Preparations
1006,1,Succinimide Derivatives
1007,1,Succinimides
1008,4,Sugar Alcohols
1009,1,Sulfanilamides
1010,1,Sulfates
1011,24,Sulfonamides
1012,23,Sulfones
1013,2,Sulfur Acids
1014,28,Sulfur Compounds
1015,2,Sulfuric Acids
1016,2,Supplements
1017,10,Sympatholytics
1018,7,Sympathomimetic (Adrenergic) Agents
1019,2,Sympathomimetic Amine Anorectic
1020,1,Sympathomimetic-like Agent
1021,31,Sympathomimetics
1022,2,Sympathomimetics Excl. Antiglaucoma Preparations
1023,2,Sympathomimetics Used as Decongestants
1024,2,Sympathomimetics in Glaucoma Therapy
1025,3,"Sympathomimetics, Labour Repressants"
1026,3,"Sympathomimetics, Plain"
1027,1,"Synthetic Anticholinergics, Quaternary Ammonium Compounds"
1028,23,"Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"
1029,4,Terpenes
1030,2,Tertiary Amines
1031,5,Testosterone Congeners
1032,2,Testosterone and derivatives
1033,1,Tests for Bile Duct Patency
1034,1,Tests for Fertility Disturbances
1035,1,Tests for Gastric Secretion
1036,1,Tests for Pituitary Function
1037,1,Tetrahydroisoquinolines
1038,1,Tetrahydronaphthalenes
1039,3,Thiadiazoles
1040,3,Thiazide-like Diuretic
1041,9,Thiazides
1042,3,Thiazoles
1043,2,Throat Preparations
1044,1,Thrombin Inhibitors
1045,7,Thyroxine-binding globulin inducers
1046,21,Thyroxine-binding globulin inhibitors
1047,1,Thyroxine-binding globulin substrates
1048,8,Tocolytic Agents
1049,2,Toxic Actions
1050,1,"Toxins, Biological"
1051,6,Tranquilizing Agents
1052,1,Treatments for Hepatitis C
1053,2,Triazoles
1054,1,Triose Sugar Alcohols
1055,2,Triterpenes
1056,1,Tropanes
1057,1,Tumor Necrosis Factor Blockers
1058,2,Tyrosine Kinase Inhibitors
1059,4,UGT1A1 Inducers
1060,3,UGT1A1 Inhibitors
1061,18,UGT1A1 Substrates
1062,7,UGT1A3 substrates
1063,1,UGT1A4 Inhibitors
1064,4,UGT1A4 substrates
1065,14,UGT1A9 Substrates
1066,2,UGT2B17 substrates
1067,1,UGT2B7 Inhibitors
1068,1,UGT2B7 Substrates with a Narrow Therapeutic Index
1069,1,UGT2B7 inducers
1070,20,UGT2B7 substrates
1071,1,Uncompetitive N-methyl-D-aspartate Receptor Antagonist
1072,1,Uncompetitive NMDA Receptor Antagonists
1073,1,Uricosuric Agents
1074,1,Urologicals
1075,1,Uterotonic agents
1076,1,Various Alimentary Tract and Metabolism Products
1077,14,Vasoconstrictor Agents
1078,21,Vasodilating Agents
1079,3,Vasodilation
1080,3,Vasodilators Used in Cardiac Diseases
1081,1,Vasopressin Analog
1082,1,Vasopressin V2 Receptor Antagonist
1083,1,Vasopressin V2 Receptor Antagonists
1084,2,Vasopressin and Analogues
1085,2,Vasopressins
1086,8,Vasoprotectives
1087,1,Venoms
1088,1,Verapamil and analogues
1089,1,Vitamin B Complex
1090,1,Vitamin B12 and Folic Acid
1091,1,Vitamins
1092,3,Wakefulness-Promoting Agents
1093,1,gamma-Aminobutyric Acid-ergic Agonist
1094,1,meta-Aminobenzoates
